| Methods and intermediates for the preparation of bile acid derivatives |
2023-7-13 |
2023-9-01 |
|
| Farnesoid x receptor modulators |
2023-4-03 |
2023-7-27 |
|
| Combination therapy |
2023-1-30 |
2023-8-03 |
|
| Isotopically labeled bile acid derivatives |
2022-9-07 |
2023-2-23 |
|
| Tgr5 modulators and methods of use thereof |
2022-4-14 |
2022-12-01 |
|
| Pharmaceutical compositions for combination therapy |
2022-3-21 |
2022-9-08 |
|
| Compositions of obeticholic acid and methods of use |
2021-12-06 |
2022-5-05 |
|
| Pharmaceutical compositions comprising a fxr agonist and a fibrate for use in … |
2021-11-22 |
2022-1-01 |
|
| Methods of treating coronaviral infection with obeticholic acid |
2021-10-07 |
2022-4-14 |
|
| Methods of diagnosis and treatment of liver diseases using obeticholic acid |
2021-9-22 |
2021-10-31 |
|
| Methods of using obeticholic acid |
2021-7-23 |
2022-6-16 |
|
| Farnesoid x receptor modulators |
2021-5-14 |
2021-9-02 |
|
| Treatment of fibrosis using fxr ligands |
2021-3-24 |
2021-11-11 |
|
| Preparation and uses of obeticholic acid |
2021-1-06 |
2021-12-23 |
|
| Tgr5 modulators and methods of use thereof |
2020-11-09 |
2021-9-02 |
|
| 3-desoxy derivative and pharmaceutical compositions thereof |
2020-9-18 |
2021-4-08 |
|
| Treatment and prevention of intestinal inflammatory diseases with a bile acid … |
2020-2-03 |
2022-11-02 |
|
| Methods of treating cancer |
2019-9-04 |
2019-11-28 |
|
| Crystalline forms of obeticholic acid |
2019-9-02 |
2019-11-28 |
|
| Pharmaceutical compositions of a bile acid derivative and microbiome and uses … |
2019-8-18 |
2019-10-31 |
|
| Pharmaceutical compositions for combination therapy |
2019-7-29 |
2022-2-01 |
|
| Methods of treating cancer |
2019-6-17 |
2019-10-03 |
|
| Crystalline forms of a bile acid derivative |
2019-3-26 |
2019-5-30 |
|
| Methods for the preparation of obeticholic acid and derivatives thereof |
2018-10-16 |
2018-12-31 |
|
| Methods and intermediates for the preparation bile acid derivatives |
2018-10-12 |
2019-7-12 |
|
| Methods for the preparation of obeticholic acid and derivatives thereof |
2018-10-12 |
2019-7-12 |
|
| Methods of promoting hepatic regeneration |
2018-10-12 |
2019-7-12 |
|
| Film-coated tablet having high chemical stability of active ingredient |
2018-10-02 |
2018-11-29 |
|
| Oral preparation having exceptional elutability |
2018-10-02 |
2018-11-29 |
|
| Medicine obtained by combining fxr agonist and arb |
2018-10-02 |
2018-11-29 |
|
| Methods for preparation of bile acids and derivatives thereof |
2018-9-18 |
2019-5-31 |
|
| Crystalline polymorphic forms of obetolic acid |
2018-6-27 |
2018-7-10 |
|
| Treatment and prevention of diabetic eye diseases with a bile acid derivatives |
2018-6-05 |
2018-12-13 |
|
| Treatment of renal diseases with a bile acid derivative |
2018-5-30 |
2018-12-06 |
|
| Preparation and Uses of Obeticholic Acid |
2018-4-30 |
2018-10-25 |
|
| Methods for modulating bone density |
2018-3-08 |
2018-7-20 |
|
| Methods for preparation of bile acids and derivatives thereof |
2018-1-17 |
2018-3-29 |
|
| PROCEDURE FOR THE PRODUCTION OF BITAL ACID PRODUCERS |
2018-1-03 |
2018-6-27 |
|
| A substituted derivative of cholanoic acid, a pharmaceutical composition … |
2017-12-04 |
2021-2-28 |
|
| Methods of treating cancer |
2017-9-21 |
2018-9-13 |
|
| Treatment of Pulmonary Disease |
2017-7-18 |
2018-3-08 |
|
| Steroids as Agonists for FXR |
2017-7-10 |
2017-10-26 |
|
| METHODS TO TREAT CANCER |
2017-4-17 |
2018-7-25 |
|
| 3-DESOXY DERIVATIVE AND RELATED PHARMACEUTICAL COMPOSITIONS |
2017-3-07 |
2019-1-16 |
|
| FOSR THERAPY USING FXR SELECTION CONNECTORS |
2017-1-27 |
2017-7-12 |
|
| Fanisole X receptor modulators |
2016-10-07 |
2023-9-29 |
2023-9-29 |
| TGR5 MODULATORS AND SAME USE METHODS |
2016-6-21 |
2018-7-11 |
|
| Tgr5 modulators and methods of use thereof tgr5 |
2016-5-05 |
2017-1-06 |
|
| PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY |
2016-4-27 |
2017-7-19 |
|
| 法尼醇x受体调节剂 |
2016-10-07 |
2023-9-29 |
2023-9-29 |